Interleukin Genetics Inc.
135 Beaver Street
Waltham
MA
02452
(781) 398-0700
FAX (781) 398-0720
Product(s):
Manufactures genetic tests for the personalized health market
Ownership:
Public
Exchange:
AMEX
symbol:
ILI
2004 Revenue:
$34,671
2005 Revenue:
$22,877
2006 Revenue:
$4,731,026
2007 Revenue:
$9,700,493
2008 Revenue:
$10,014,980
Yahoo Quotes:
President:
Kenneth S. Kornman
CEO:
Lewis H. Bender Management:
Eliot M. Lurier, CFO
Kenneth S. Kornman, president, Chief Scientific Officer
Nazneen Aziz, VP-R&D
Todd Anthony Walker, VP-marketing
Permalink
RECENT BLOG POSTS
- Is Valeant About To Make A Bold Bid For Bausch & Lomb?
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
